Sequence information
Variant position: 1205 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1235 The length of the canonical sequence.
Location on the sequence:
MDTLEKDQATGICHFFYDSA
P SGAYGTMTYLTRAVASYLQE
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human MDTLEKDQATGICHFFYDSAP SGAYGTMTYLTRAVASYLQE
Mouse TDILEKDQATGICHLFYDSAP SGAYGTMTYLTKAVASHLQE
Rabbit MDTLEKDQATGICHFFYDSAP SGAYGTMTYLTRAVASHLQE
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 1235
Phosphorylase b kinase regulatory subunit alpha, liver isoform
Literature citations
X-linked liver phosphorylase kinase deficiency is associated with mutations in the human liver phosphorylase kinase alpha subunit.
van den Berg I.E.T.; van Beurden E.A.C.M.; Malingre H.E.M.; Ploos van Amstel H.K.; Poll-The B.T.; Smeitink J.A.M.; Lamers W.H.; Berger R.;
Am. J. Hum. Genet. 56:381-387(1995)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANTS GSD9A PHE-141 DEL AND LEU-1205;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.